Catégories
Documents English-site Tout le CNR-MyRMA

Publications du CNR-MyRMA

Publications of the NRC

Publications 2019

Cliquer ici pour toutes les publications du CNR-MyRMA en 2019

Publications 2018

Cliquer ici pour toutes les publications du CNR-MyRMA en 2018

Publications 2017

Cliquer ici pour toutes les publications du CNR-MyRMA en 2017

Publications 2016

Cliquer ici pour toutes les publications du CNR-MyRMA en 2016

Publications 2015

Cliquer ici pour toutes les publications du CNR-MyRMA en 2015

Publications 2014

Cliquer ici pour toutes les publications du CNR-MyRMA en 2014

Publications 2013

Cliquer ici pour toutes les publications du CNR-MyRMA en 2013

1368488 {1368488:HRKPMGKG} 1 art-libraries-society-of-north-america-arlisna-reviews 50 default 238 https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22HRKPMGKG%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Veziris%20et%20al.%22%2C%22parsedDate%22%3A%222013-11-14%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26%23x201C%3BResistance%20of%20M.%20Leprae%20to%20Quinolones%3A%20A%20Question%20of%20Relativity%3F%26%23x201D%3B%20by%20Nicolas%20Veziris%20et%20al.%20%26lt%3Bi%26gt%3BPLoS%20Negl%20Trop%20Dis%26lt%3B%5C%2Fi%26gt%3B.%207%2C%20no.%2011%20%28November%2014%2C%202013%29.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0002559%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0002559%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Resistance%20of%20M.%20leprae%20to%20Quinolones%3A%20A%20Question%20of%20Relativity%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aurelie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvie%22%2C%22lastName%22%3A%22Escolano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Henquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masanori%22%2C%22lastName%22%3A%22Matsuoka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22Author%20SummaryAlthough%20there%20is%20efficient%20multidrug%20therapy%20to%20cure%20leprosy%2C%20the%20transmission%20of%20M.%20leprae%20is%20still%20active%2C%20leading%20to%20219%2C000%20new%20cases%20in%202011.%20Drug%20resistant%20leprosy%20has%20been%20described%20and%20may%20prevent%20eradication%20of%20the%20disease%2C%20notably%20multidrug%20resistant%20defined%20as%20resistance%20to%20rifampin%2C%20dapsone%20and%20fluoroquinolones%20%28FQ%29.%20Resistance%20to%20FQ%20is%20due%20to%20mutations%20in%20DNA%20gyrase.%20We%20used%20a%20mouse%20model%20to%20measure%20the%20impact%20of%20DNA%20gyrase%20mutations%20on%20in%20vivo%20FQ%20activity.%20All%20the%20FQ%20tested%20showed%20in%20vivo%20activity%20against%20the%20mutant%20tested%20%28A91V%20mutant%20in%20subunit%20A%20of%20DNA%20gyrase%29.%20However%2C%20whereas%20ofloxacin%20was%20less%20active%20than%20the%20control%20treatment%20clarithromycin%2C%20it%20appeared%20that%20latter%20generation%20fluoroquinolones%20moxifloxacin%20and%20garenoxacin%20were%20as%20active%20as%20clarithromycin.%20Our%20results%20demonstrate%20that%20DNA%20gyrase%20mutation%20is%20not%20synonymous%20of%20total%20lack%20of%20in%20vivo%20FQ%20activity%20against%20M.%20leprae.%20Therefore%2C%20as%20for%20M.%20tuberculosis%2C%20in%20vivo%20studies%20are%20mandatory%20in%20order%20to%20measure%20the%20impact%20of%20DNA%20gyrase%20mutations%20on%20treatment%20efficacy%20against%20M.%20leprae.%22%2C%22date%22%3A%22November%2014%2C%202013%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pntd.0002559%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fdx.doi.org%5C%2F10.1371%5C%2Fjournal.pntd.0002559%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A28%3A18Z%22%7D%7D%5D%7D
“Resistance of M. Leprae to Quinolones: A Question of Relativity?” by Nicolas Veziris et al. PLoS Negl Trop Dis. 7, no. 11 (November 14, 2013). https://doi.org/10.1371/journal.pntd.0002559.
Publications 2012

Cliquer ici pour toutes les publications du CNR-MyRMA en 2012 / click here

1368488 {1368488:JT79M536} 1 art-libraries-society-of-north-america-arlisna-reviews 50 default 239 https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22JT79M536%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pantel%20et%20al.%22%2C%22parsedDate%22%3A%222012-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26%23x201C%3BExtending%20the%20Definition%20of%20the%20GyrB%20Quinolone%20Resistance-Determining%20Region%20in%20Mycobacterium%20Tuberculosis%20DNA%20Gyrase%20for%20Assessing%20Fluoroquinolone%20Resistance%20in%20M.%20Tuberculosis%26%23x201D%3B%20by%20Alix%20Pantel%20et%20al.%20%26lt%3Bi%26gt%3BAntimicrobial%20Agents%20and%20Chemotherapy%26lt%3B%5C%2Fi%26gt%3B.%2056%2C%20no.%204%20%28April%202012%29.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.06272-11%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.06272-11%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Extending%20the%20Definition%20of%20the%20GyrB%20Quinolone%20Resistance-Determining%20Region%20in%20Mycobacterium%20tuberculosis%20DNA%20Gyrase%20for%20Assessing%20Fluoroquinolone%20Resistance%20in%20M.%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alix%22%2C%22lastName%22%3A%22Pantel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Petrella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvaine%22%2C%22lastName%22%3A%22Bastian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudine%22%2C%22lastName%22%3A%22Mayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22Fluoroquinolone%20%28FQ%29%20resistance%20is%20emerging%20in%20Mycobacterium%20tuberculosis.%20The%20main%20mechanism%20of%20FQ%20resistance%20is%20amino%20acid%20substitution%20within%20the%20quinolone%20resistance-determining%20region%20%28QRDR%29%20of%20the%20GyrA%20subunit%20of%20DNA%20gyrase%2C%20the%20sole%20FQ%20target%20in%20M.%20tuberculosis.%20However%2C%20substitutions%20in%20GyrB%20whose%20implication%20in%20FQ%20resistance%20is%20unknown%20are%20increasingly%20being%20reported.%20The%20present%20study%20clarified%20the%20role%20of%20four%20GyrB%20substitutions%20identified%20in%20M.%20tuberculosis%20clinical%20strains%2C%20two%20located%20in%20the%20QRDR%20%28D500A%20and%20N538T%29%20and%20two%20outside%20the%20QRDR%20%28T539P%20and%20E540V%29%2C%20in%20FQ%20resistance.%20We%20measured%20FQ%20MICs%20and%20also%20DNA%20gyrase%20inhibition%20by%20FQs%20in%20order%20to%20unequivocally%20clarify%20the%20role%20of%20these%20mutations%20in%20FQ%20resistance.%20Wild-type%20GyrA%2C%20wild-type%20GyrB%2C%20and%20mutant%20GyrB%20subunits%20produced%20from%20engineered%20gyrB%20alleles%20by%20mutagenesis%20were%20overexpressed%20in%20Escherichia%20coli%2C%20purified%20to%20homogeneity%2C%20and%20used%20to%20reconstitute%20highly%20active%20gyrase%20complexes.%20MICs%20and%20DNA%20gyrase%20inhibition%20were%20determined%20for%20moxifloxacin%2C%20gatifloxacin%2C%20ofloxacin%2C%20levofloxacin%2C%20and%20enoxacin.%20All%20these%20substitutions%20are%20clearly%20implicated%20in%20FQ%20resistance%2C%20underlining%20the%20presence%20of%20a%20hot%20spot%20region%20housing%20most%20of%20the%20GyrB%20substitutions%20implicated%20in%20FQ%20resistance%20%28residues%20NTE%2C%20538%20to%20540%29.%20These%20findings%20help%20us%20to%20refine%20the%20definition%20of%20GyrB%20QRDR%2C%20which%20is%20extended%20to%20positions%20500%20to%20540.%22%2C%22date%22%3A%222012-4%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.06272-11%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3318379%5C%2F%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220066-4804%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A54%3A20Z%22%7D%7D%5D%7D
“Extending the Definition of the GyrB Quinolone Resistance-Determining Region in Mycobacterium Tuberculosis DNA Gyrase for Assessing Fluoroquinolone Resistance in M. Tuberculosis” by Alix Pantel et al. Antimicrobial Agents and Chemotherapy. 56, no. 4 (April 2012). https://doi.org/10.1128/AAC.06272-11.
Publications 2011

Cliquer ici pour toutes les publications du CNR-MyRMA en 2011 / click here

1368488 {1368488:6RTU8WMI} 1 art-libraries-society-of-north-america-arlisna-reviews 50 default 794 https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%226RTU8WMI%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Petrella%20et%20al.%22%2C%22parsedDate%22%3A%222011-01-24%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26%23x201C%3BCrystal%20Structure%20of%20the%20Pyrazinamidase%20of%20Mycobacterium%20Tuberculosis%26%23x202F%3B%3A%20Insights%20into%20Natural%20and%20Acquired%20Resistance%20to%20Pyrazinamide%26%23x201D%3B%20by%20St%26%23xE9%3Bphanie%20Petrella%20et%20al.%20%26lt%3Bi%26gt%3BPLOS%20ONE%26lt%3B%5C%2Fi%26gt%3B.%206%2C%20no.%201%20%28January%2024%2C%202011%29.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0015785%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0015785%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Crystal%20Structure%20of%20the%20Pyrazinamidase%20of%20Mycobacterium%20tuberculosis%20%3A%20Insights%20into%20Natural%20and%20Acquired%20Resistance%20to%20Pyrazinamide%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Petrella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Gelus-Ziental%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnaud%22%2C%22lastName%22%3A%22Maudry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Laurans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachid%22%2C%22lastName%22%3A%22Boudjelloul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%5D%2C%22abstractNote%22%3A%22Pyrazinamidase%20%28PncA%29%20activates%20the%20first-line%20antituberculous%20drug%20pyrazinamide%20into%20pyrazinoic%20acid.%20The%20crystal%20structure%20of%20the%20%20Mycobacterium%20tuberculosis%20%20PncA%20protein%20has%20been%20determined%2C%20showing%20significant%20differences%20in%20the%20substrate%20binding%20cavity%20when%20compared%20to%20the%20pyrazinamidases%20from%20%20Pyrococcus%20horikoshii%20%20and%20%20Acinetobacter%20baumanii%20.%20In%20%20M.%20tuberculosis%20%2C%20this%20region%20was%20found%20to%20hold%20a%20Fe%202%2B%20%20ion%20coordinated%20by%20one%20aspartate%20and%20three%20histidines%2C%20one%20of%20them%20corresponding%20to%20His57%20which%20is%20replaced%20by%20Asp%20in%20%20Mycobacterium%20bovis%20%2C%20a%20species%20naturally%20resistant%20to%20pyrazinamide.%20The%20binding%20cavity%20also%20contains%20a%20Cys138-Asp8-Lys96%20motif%20evocating%20a%20cysteine-based%20catalytic%20mechanism.%20Mutants%20have%20been%20constructed%20and%20investigated%20by%20kinetic%20and%20thermal%20shift%20assays%2C%20highlighting%20the%20importance%20of%20protein%20folding%20and%20thermal%20stability%20in%20the%20pyrazinamidase%20activity.%22%2C%22date%22%3A%2224%20janv.%202011%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0015785%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjournals.plos.org%5C%2Fplosone%5C%2Farticle%3Fid%3D10.1371%5C%2Fjournal.pone.0015785%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221932-6203%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-25T05%3A39%3A38Z%22%7D%7D%5D%7D
“Crystal Structure of the Pyrazinamidase of Mycobacterium Tuberculosis : Insights into Natural and Acquired Resistance to Pyrazinamide” by Stéphanie Petrella et al. PLOS ONE. 6, no. 1 (January 24, 2011). https://doi.org/10.1371/journal.pone.0015785.
Publications 2010

Cliquer ici pour toutes les publications du CNR-MyRMA en 2010 / click here

1368488 {1368488:5KB9RK5J} 1 art-libraries-society-of-north-america-arlisna-reviews 50 default 799 https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%225KB9RK5J%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brossier%20et%20al.%22%2C%22parsedDate%22%3A%222010-05-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26%23x201C%3BDetection%20by%20GenoType%20MTBDRsl%20Test%20of%20Complex%20Mechanisms%20of%20Resistance%20to%20Second-Line%20Drugs%20and%20Ethambutol%20in%20Multidrug-Resistant%20Mycobacterium%20Tuberculosis%20Complex%20Isolates%26%23x201D%3B%20by%20Florence%20Brossier%20et%20al.%20%26lt%3Bi%26gt%3BJournal%20of%20Clinical%20Microbiology%26lt%3B%5C%2Fi%26gt%3B.%2048%2C%20no.%205%20%28May%201%2C%202010%29.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.01947-09%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.01947-09%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Detection%20by%20GenoType%20MTBDRsl%20Test%20of%20Complex%20Mechanisms%20of%20Resistance%20to%20Second-Line%20Drugs%20and%20Ethambutol%20in%20Multidrug-Resistant%20Mycobacterium%20tuberculosis%20Complex%20Isolates%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%5D%2C%22abstractNote%22%3A%22The%20GenoType%20MTBDRsl%20test%20rapidly%20detects%20resistance%20to%20ethambutol%2C%20fluoroquinolones%2C%20and%20second-line%20aminoglycosides%20%28amikacin%20and%20kanamycin%29%20and%20cyclic%20peptide%20%28capreomycin%29%20in%20Mycobacterium%20tuberculosis.%20A%20set%20of%2041%20multidrug-resistant%20%28MDR%29%20M.%20tuberculosis%20strains%2C%208%20extensively%20drug-resistant%20%28XDR%29%20M.%20tuberculosis%20strains%2C%20and%203%20non-MDR%20M.%20tuberculosis%20strains%20were%20tested%20by%20the%20MTBDRsl%20test%20and%20by%20DNA%20sequencing%20of%20the%20resistance-determining%20regions%20in%20gyrA%20and%20gyrB%20%28fluoroquinolones%20%5BFQ%5D%29%2C%20rpsL%20%28streptomycin%29%2C%20rrs%20and%20tlyA%20%28aminoglycosides%20and%5C%2For%20cyclic%20peptide%29%2C%20and%20embB%20%28ethambutol%29.%20The%20sensitivity%20and%20specificity%20of%20the%20MTBDRsl%20test%20were%20as%20follows%3A%2087%25%20and%2096%25%2C%20respectively%2C%20for%20fluoroquinolones%3B%20100%25%20for%20both%20for%20amikacin%3B%2077%25%20and%20100%25%2C%20respectively%2C%20for%20kanamycin%2C%2080%25%20and%2098%25%2C%20respectively%2C%20for%20capreomycin%3B%20and%2057%25%20and%2092%25%2C%20respectively%2C%20for%20ethambutol.%20Analysis%20of%20the%20discrepant%20results%20indicated%20that%20three%20FQ-resistant%20strains%20%28including%20one%20XDR%20strain%29%20with%20mutations%20in%20gyrB%20were%20missed%20by%20the%20MTBDRsl%20test%20and%20that%20one%20FQ-susceptible%20strain%2C%20identified%20as%20resistant%20by%20the%20MTBDRsl%20test%2C%20had%20a%20double%20mutation%20%28T80A-A90G%29%20in%20GyrA%20that%20did%20not%20confer%20resistance%20to%20FQ.%20Five%20strains%20%28including%20two%20XDR%20strains%29%20without%20mutations%20in%20rrs%20were%20monoresistant%20to%20aminoglycosides%20or%20cyclic%20peptide%20and%20were%20missed%20by%20the%20MTBDRsl%20test.%20Finally%2C%2012%5C%2F28%20ethambutol-resistant%20strains%20had%20no%20mutation%20at%20codon%20306%20in%20embB%2C%20while%202%5C%2F24%20ethambutol-susceptible%20strains%20had%20such%20a%20mutation.%20In%20conclusion%2C%20the%20MTBDRsl%20test%20efficiently%20detects%20the%20most%20common%20mutations%20involved%20in%20resistance%20to%20fluoroquinolones%2C%20aminoglycosides%5C%2Fcyclic%20peptide%2C%20and%20ethambutol%20and%20accurately%20assesses%20susceptibility%20to%20amikacin.%20However%2C%20due%20to%20mutations%20not%20included%20in%20the%20test%20%28particularly%20in%20gyrB%29%20or%20resistance%20mechanisms%20not%20yet%20characterized%20%28particularly%20those%20related%20to%20ethambutol%20resistance%20and%20to%20monoresistance%20to%20aminoglycosides%20or%20cyclic%20peptide%29%2C%20the%20wild-type%20results%20yielded%20by%20the%20MTBDRsl%20test%20should%20be%20confirmed%20by%20drug%20susceptibility%20testing.%22%2C%22date%22%3A%2205%5C%2F01%5C%2F2010%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FJCM.01947-09%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjcm.asm.org%5C%2Fcontent%5C%2F48%5C%2F5%5C%2F1683%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222013-09-02T12%3A22%3A37Z%22%7D%7D%5D%7D
“Detection by GenoType MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium Tuberculosis Complex Isolates” by Florence Brossier et al. Journal of Clinical Microbiology. 48, no. 5 (May 1, 2010). https://doi.org/10.1128/JCM.01947-09.